Literature DB >> 4288482

Corticotropin in generalized myasthenia gravis. Effect of short, intensive courses.

D Grob, T Namba.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 4288482

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  8 in total

Review 1.  Immunopathology of acetylcholine receptors in myasthenia gravis.

Authors:  M E Seybold; J M Lindstrom
Journal:  Springer Semin Immunopathol       Date:  1982

2.  Controversies about the treatment of myasthenia gravis.

Authors:  L P Rowland
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-07       Impact factor: 10.154

3.  The immunological effects of thymectomy in myasthenia gravis.

Authors:  G K Scadding; H C Thomas; C W Havard
Journal:  Clin Exp Immunol       Date:  1979-05       Impact factor: 4.330

4.  Ventilatory failure in myasthenia gravis.

Authors:  I T Ferguson; R P Murphy; R G Lascelles
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-03       Impact factor: 10.154

5.  Treatment of myasthenia gravis with adrenocorticotropic hormone (ACTH): massive short-term and maintenance treatment.

Authors:  C A Cape; R A Utterback
Journal:  J Neurol Neurosurg Psychiatry       Date:  1969-08       Impact factor: 10.154

6.  Treatment of ocular myasthenia with corticotrophin.

Authors:  F B Gibberd; F Navab; C L Smith
Journal:  J Neurol Neurosurg Psychiatry       Date:  1971-02       Impact factor: 10.154

7.  Multiple sclerosis associated with defects in neuromuscular transmission.

Authors:  B M Patten; A Hart; R Lovelace
Journal:  J Neurol Neurosurg Psychiatry       Date:  1972-06       Impact factor: 10.154

Review 8.  Current Treatment of Myasthenia Gravis.

Authors:  Mohammed K Alhaidar; Sumayyah Abumurad; Betty Soliven; Kourosh Rezania
Journal:  J Clin Med       Date:  2022-03-14       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.